Strengthening provider-initiated testing and counselling in Zimbabwe by deploying supplemental providers: a time series analysis.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
03 Jun 2019
Historique:
received: 02 10 2018
accepted: 20 05 2019
entrez: 5 6 2019
pubmed: 5 6 2019
medline: 24 9 2019
Statut: epublish

Résumé

Expansion of provider-initiated testing and counselling (PITC) is one strategy to increase accessibility of HIV testing services. Insufficient human resources was identified as a primary barrier to increasing PITC coverage in Zimbabwe. We evaluated if deployment of supplemental PITC providers at public facilities in Zimbabwe was associated with increased numbers of individuals tested and diagnosed with HIV. From July 2016 to May 2017, International Training and Education Center for Health (I-TECH) deployed 138 PITC providers to supplement existing ministry healthcare workers offering PITC at 249 facilities. These supplemental providers were assigned to facilities on a weekly basis. Each week, I-TECH providers reported the number of HIV tests and positive diagnoses they performed. Using routine reporting systems, we obtained from each facility the number of clients tested and diagnosed with HIV per month. Including data both before and during the intervention period, and utilizing the weekly variability in placement locations of the supplemental PITC providers, we employed generalized estimating equations to assess if the placement of supplemental PITC providers at a facility was associated with a change in facility outputs. Supplemental PITC providers performed an average of 62 (SD = 52) HIV tests per week and diagnosed 4.4 (SD = 4.9) individuals with HIV per week. However, using facility reports from the same period, we found that each person-week of PITC provider deployment at a facility was associated with an additional 16.7 (95% CI, 12.2-21.1) individuals tested and an additional 0.9 (95% CI, 0.5-1.2) individuals diagnosed with HIV. We also found that staff placement at clinics was associated with a larger increase in HIV testing than staff placement at polyclinics or hospitals (24.0 vs. 9.8; p < 0.001). This program resulted in increased numbers of individuals tested and diagnosed with HIV. The discrepancy between the average weekly HIV tests conducted by supplemental PITC providers (62) and the increase in facility-level HIV tests associated with one week of PITC provider deployment (16.7) suggests that supplemental PITC providers displaced existing staff who may have been reassigned to fulfil other duties at the facility.

Sections du résumé

BACKGROUND BACKGROUND
Expansion of provider-initiated testing and counselling (PITC) is one strategy to increase accessibility of HIV testing services. Insufficient human resources was identified as a primary barrier to increasing PITC coverage in Zimbabwe. We evaluated if deployment of supplemental PITC providers at public facilities in Zimbabwe was associated with increased numbers of individuals tested and diagnosed with HIV.
METHODS METHODS
From July 2016 to May 2017, International Training and Education Center for Health (I-TECH) deployed 138 PITC providers to supplement existing ministry healthcare workers offering PITC at 249 facilities. These supplemental providers were assigned to facilities on a weekly basis. Each week, I-TECH providers reported the number of HIV tests and positive diagnoses they performed. Using routine reporting systems, we obtained from each facility the number of clients tested and diagnosed with HIV per month. Including data both before and during the intervention period, and utilizing the weekly variability in placement locations of the supplemental PITC providers, we employed generalized estimating equations to assess if the placement of supplemental PITC providers at a facility was associated with a change in facility outputs.
RESULTS RESULTS
Supplemental PITC providers performed an average of 62 (SD = 52) HIV tests per week and diagnosed 4.4 (SD = 4.9) individuals with HIV per week. However, using facility reports from the same period, we found that each person-week of PITC provider deployment at a facility was associated with an additional 16.7 (95% CI, 12.2-21.1) individuals tested and an additional 0.9 (95% CI, 0.5-1.2) individuals diagnosed with HIV. We also found that staff placement at clinics was associated with a larger increase in HIV testing than staff placement at polyclinics or hospitals (24.0 vs. 9.8; p < 0.001).
CONCLUSIONS CONCLUSIONS
This program resulted in increased numbers of individuals tested and diagnosed with HIV. The discrepancy between the average weekly HIV tests conducted by supplemental PITC providers (62) and the increase in facility-level HIV tests associated with one week of PITC provider deployment (16.7) suggests that supplemental PITC providers displaced existing staff who may have been reassigned to fulfil other duties at the facility.

Identifiants

pubmed: 31159809
doi: 10.1186/s12913-019-4169-z
pii: 10.1186/s12913-019-4169-z
pmc: PMC6547585
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

351

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009539
Pays : United States
Organisme : U.S. President's Emergency Plan for AIDS Relief
ID : NU2GGH001188

Références

Am J Public Health. 2006 Jan;96(1):114-9
pubmed: 16317205
Hum Resour Health. 2006 Aug 24;4:23
pubmed: 16930480
Hum Resour Health. 2009 Feb 10;7:8
pubmed: 19208253
Lancet. 2009 Jun 20;373(9681):2137-69
pubmed: 19541040
AIDS Care. 2010 Feb;22(2):238-45
pubmed: 20390502
J Acquir Immune Defic Syndr. 2010 Jul;54(3):317-23
pubmed: 20453819
AIDS Care. 2010;22 Suppl 1:93-102
pubmed: 20680864
Bull World Health Organ. 2011 May 1;89(5):328-335A
pubmed: 21556300
AIDS. 2013 Feb 20;27(4):617-26
pubmed: 23364442
PLoS One. 2014 Apr 17;9(4):e95459
pubmed: 24743295
PLoS Med. 2014 May 27;11(5):e1001649
pubmed: 24866209
Risk Manag Healthc Policy. 2014 May 16;7:91-8
pubmed: 24876798
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):e24-9
pubmed: 26473799
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Trop Med Int Health. 2016 Apr;21(4):479-85
pubmed: 26806378
Lancet HIV. 2016 May;3(5):e221-30
pubmed: 27126489

Auteurs

Aaron F Bochner (AF)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA. bochner@uw.edu.
Department of Epidemiology, University of Washington, 325 9th Ave, Box 359932, Seattle, WA, 98104, USA. bochner@uw.edu.

Beth A Tippett Barr (BA)

U.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.

Batsirai Makunike (B)

International Training and Education Center for Health (I-TECH), Harare, Zimbabwe.

Gloria Gonese (G)

International Training and Education Center for Health (I-TECH), Harare, Zimbabwe.

Blessing Wazara (B)

International Training and Education Center for Health (I-TECH), Harare, Zimbabwe.

Richard Mashapa (R)

International Training and Education Center for Health (I-TECH), Harare, Zimbabwe.

Elizabeth Meacham (E)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA.

Ponesai Nyika (P)

U.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.

Gertrude Ncube (G)

Ministry of Health and Child Care, Harare, Zimbabwe.

Shirish Balachandra (S)

U.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.

Ruth Levine (R)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA.

Frances Petracca (F)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA.

Tsitsi Apollo (T)

Ministry of Health and Child Care, Harare, Zimbabwe.

Ann Downer (A)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA.

Stefan Z Wiktor (SZ)

International Training and Education Center for Health (I-TECH), Department of Global Health, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH